7-(2-(3,6-Dihydro-4-(3-(trifluoromethyl)phenyl)-1(2H)-pyridinyl)ethyl)isoquinoline
Isoquinoline, 7-(2-(3,6-dihydro-4-(3-(trifluoromethyl)phenyl)-1(2h)-pyridinyl)ethyl)- is under investigation in clinical trial NCT00545454 (Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid Arthritis).